Olivier Devuyst

35.6k total citations · 5 hit papers
364 papers, 17.7k citations indexed

About

Olivier Devuyst is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Olivier Devuyst has authored 364 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Molecular Biology, 118 papers in Nephrology and 84 papers in Genetics. Recurrent topics in Olivier Devuyst's work include Ion Transport and Channel Regulation (113 papers), Genetic and Kidney Cyst Diseases (71 papers) and Renal and related cancers (58 papers). Olivier Devuyst is often cited by papers focused on Ion Transport and Channel Regulation (113 papers), Genetic and Kidney Cyst Diseases (71 papers) and Renal and related cancers (58 papers). Olivier Devuyst collaborates with scholars based in Belgium, Switzerland and United States. Olivier Devuyst's co-authors include Vicente E. Torres, Arlene B. Chapman, Ronald D. Perrone, Ron T. Gansevoort, Frank S. Czerwiec, John Ouyang, Luca Rampoldi, Yves Pirson, Kai‐Uwe Eckardt and William B. Guggino and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Olivier Devuyst

353 papers receiving 17.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

2012 1.1k citations Vicente E. Torres, Arlene B. Chapman et al. profile →
Evolving importance of kidney disease: from subspecialty to global health burden

2013 796 citations Olivier Devuyst et al. The Lancet profile →
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

2017 398 citations Vicente E. Torres, Arlene B. Chapman et al. profile →
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

2015 384 citations Arlene B. Chapman, Olivier Devuyst et al. profile →
The Current State of Peritoneal Dialysis

2016 346 citations Olivier Devuyst et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by Olivier Devuyst

Since Specialization

Citations

This map shows the geographic impact of Olivier Devuyst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Devuyst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Devuyst more than expected).

Fields of papers citing papers by Olivier Devuyst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Devuyst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Devuyst. The network helps show where Olivier Devuyst may publish in the future.

Co-authorship network of co-authors of Olivier Devuyst

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Devuyst. A scholar is included among the top collaborators of Olivier Devuyst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Devuyst. Olivier Devuyst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AQP1: a regulatory factor associated with brown adipose tissue-silencing to combat obesity and metabolic disease 2025 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yang Liu, (unknown), (unknown), (unknown), (unknown), (unknown), Olivier Devuyst, (unknown)	1
2	Dent disease: clinical practice recommendations 2025 ·Nephrology Dialysis Transplantation ·Arend Bökenkamp, Gema Ariceta, Detlef Böckenhauer, Olivier Devuyst, Francesco Emma, (unknown), Elena Levtchenko, John A. Sayer, Aude Servais, Rosa Vargas‐Poussou, Marcin Zaniew, Larisa Prikhodina	0
3	UMOD Genotype and Determinants of Urinary Uromodulin in African Populations 2024 ·Kidney International Reports ·(unknown), Eric Olinger, (unknown), Ian Wilson, Catharina M. C. Mels, Ruan Kruger, Lebo F. Gafane‐Matemane, John A. Sayer, Cristian Ricci, Aletta E. Schutte, Olivier Devuyst	0
4	Systematic Scoping Review of Socioeconomic Burden and Associated Psychosocial Impact in Patients With Rare Kidney Diseases and Their Caregivers 2024 ·Kidney International Reports ·Anna Palagyi, (unknown), (unknown), Charu Malik, Jonathan Barratt, Olivier Devuyst, Ifeoma Ulasi, (unknown), Siyuan Wang, Blake Angell, Vivekanand Jha, Stephen Jan	0
5	The CTNS-MTORC1 axis couples lysosomal cystine to epithelial cell fate decisions and is a targetable pathway in cystinosis 2023 ·Autophagy ·Alessandro Luciani, Olivier Devuyst	4
6	The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial 2021 ·Journal of the American Society of Nephrology ·(unknown), Ron T. Gansevoort, Vicente E. Torres, Olivier Devuyst, Ronald D. Perrone, Jennifer Lee, Hui Li, John Ouyang, Arlene B. Chapman	7
7	Architecture and function of human uromodulin filaments in urinary tract infections 2020 ·Science ·Gregor L. Weiss, (unknown), Maximilian M. Sauer, Chia‐Wei Lin, (unknown), Dawid Zyla, Johannes Trück, Olivier Devuyst, Markus Aebi, Martin Pilhofer, Rudi Glockshuber	84
8	Author Correction: Impaired mitophagy links mitochondrial disease to epithelial stress in methylmalonyl-CoA mutase deficiency 2020 ·Nature Communications ·Alessandro Luciani, Anke Schumann, Marine Berquez, Zhiyong Chen, (unknown), (unknown), Huguette Debaix, Beatrice Paola Festa, Natsuko Tokonami, Andrea Raimondi, Alessio Cremonesi, Diego Carrella, Patrick Forny, Stefan Kölker, Francesca Diomedi‐Camassei, Francisca Díaz, Carlos T. Moraes, Diego di Bernardo, Matthias R. Baumgartner, Olivier Devuyst	1
9	Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis 2020 ·Journal of the American Society of Nephrology ·(unknown), Mohamed A. Elmonem, (unknown), Marine Berquez, Beatrice Paola Festa, (unknown), Francesco Bellomo, Tobias Starborg, Manoe J. Janssen, Zeinab Abbaszadeh, Sara Cairoli, Bianca Maria Goffredo, Rosalinde Masereeuw, Olivier Devuyst, Martin Lowe, Elena Levtchenko, Alessandro Luciani, Francesco Emma, Laura Rita Rega	34
10	The cryo-EM structure of the human uromodulin filament core reveals a unique assembly mechanism 2020 ·eLife ·(unknown), Dawid Zyla, Pavel Afanasyev, Jingwei Xu, (unknown), Eric Olinger, Olivier Devuyst, Martin Pilhofer, Daniel Boehringer, Rudi Glockshuber	30
11	Resistance to Insulin in Patients with Gitelman Syndrome and a Subtle Intermediate Phenotype in Heterozygous Carriers: A Cross-Sectional Study 2019 ·Journal of the American Society of Nephrology ·Anne Blanchard, Marion Vallet, Laurence Dubourg, Marguerite Hureaux, Julien Allard, Jean‐Philippe Haymann, Renaud de la Faille, Armelle Arnoux, (unknown), Damien Bergerot, (unknown), Pierre‐Yves Courand, Stéphanie Baron, Pascal Houillier, Ivan Tack, Olivier Devuyst, Xavier Jeunemaı̂tre, Michel Azizi, Rosa Vargas‐Poussou	27
12	Impaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney 2018 ·Nature Communications ·Beatrice Paola Festa, Zhiyong Chen, Marine Berquez, Huguette Debaix, Natsuko Tokonami, (unknown), Glenn van de Hoek, Alessio Cremonesi, Andrea Raimondi, Nathalie Névo, Rachel H. Giles, Olivier Devuyst, Alessandro Luciani	103
13	The vasopressin system: new insights for patients with kidney diseases 2017 ·Journal of Internal Medicine ·William F. Clark, Olivier Devuyst, Ronan Roussel	14
14	Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial 2016 ·Journal of the American Society of Nephrology ·Olivier Devuyst, Arlene B. Chapman, Ron T. Gansevoort, Eiji Higashihara, Ronald D. Perrone, Vicente E. Torres, Jaime D. Blais, Wen Zhou, John Ouyang, Frank S. Czerwiec	65
15	Autosomal dominant polycystic kidney disease: the changing face of clinical management 2015 ·The Lancet ·Albert Ong, Olivier Devuyst, Bertrand Knebelmann, Gerd Walz	192
16	Expression of Renal Cystic Genes in Patients with <i>HNF1B </i>Mutations 2012 ·Nephron Clinical Practice ·Stanislas Faguer, Stéphane Decramer, Olivier Devuyst, Jean‐Philippe Lengelé, Gilbert J. Fournié, Dominique Chauveau	7
17	Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion 2009 ·Nephrology Dialysis Transplantation ·(unknown), François Jouret, Étienne Marbaix, Christine Delporte, Shigeo Horie, Sharon Mulroy, Catherine A. Boulter, Richard Sandford, Olivier Devuyst	28
18	Renal expression of parvalbumin is critical for NaCl handling and response to diuretics 2007 ·Proceedings of the National Academy of Sciences ·Hendrica Belge, Philippe Gailly, Beat Schwaller, Johannes Loffing, Huguette Debaix, Eva Riveira‐Muñoz, Renaud Beauwens, Jean‐Pierre Devogelaer, Joost G.J. Hoenderop, René J.M. Bindels, Olivier Devuyst	67
19	PKD1 Haploinsufficiency Causes a Syndrome of Inappropriate Antidiuresis in Mice 2007 ·Journal of the American Society of Nephrology ·(unknown), Sara Terryn, Giovanna Valenti, Nathalie Caron, (unknown), Danielle Raufaste, Søren Drud-Heydary Nielsen, Shigeo Horie, Jean‐Marc Verbavatz, Olivier Devuyst	60
20	Improving allograft survival 2005 ·Nephrology Dialysis Transplantation ·Hallvard Holdaas, Bengt Fellström, Alan G. Jardine, Edward Cole, Gudrun Nyberg, Carola Grönhagen‐Riska, Bart Maes, Hans‐Hellmut Neumayer, Sören Madsen, (unknown), Terje Pedersen, Anders Olsson, Hendrica Belge, Philippe Gailly, (unknown), Johannes Loffing, Renaud Beauwens, Olivier Devuyst	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact